期刊文献+

来曲唑的制备 被引量:1

Preparation of letrozole
下载PDF
导出
摘要 本文研究了抗癌药物来曲唑的三步合成法。第一步:在醇类溶剂中,20℃以下,4,4’-二氰基二苯甲酮经硼氢化钠还原生成4,4’-二氰基二苯甲醇;第二步:在非极性溶剂中,4,4’-二氰基二苯甲醇经氯代反应生成4,4’-二氰基二苯基氯甲烷;第三步:在混合溶剂中,80℃左右,4,4’-二氰基二苯基氯甲烷与1,2,4-三氮唑缩合反应生成来曲唑,总产率大于50%,质量符合USP30标准,且该工艺操作简便、安全,原料成本低,适合于来曲唑的工艺化大生产。 SThrough three steps to synthesize anticancer drug letrozole were studied.First,in the alcohol solvent,below 20 ℃,through sodium borohydride reduction of bis-(4-cyanphenyl)-ketone to bis-(4-cyanphenyl)-methanol ;Second Step;in the non-polar solvent,through chlorination of bis-(4-cyanphenyl)-methanol to chloro-bis-(4-cyanophenyl)-methane;Finally;in the mixed solvent,about 80 ℃,through condensation of chloro-bis-(4-cyanophenyl)-methane and 1,2,4-triazole to letrozole.The gross production rate is more than 50%,in line with USP30 quality standards,the process is simple,safe,low cost of raw materials and suitable for the process of large-scale production.
作者 汤小芳
出处 《化工中间体》 2012年第10期36-39,共4页
关键词 来曲唑 硼氢化钠 氯代反应 缩合 Letrozole sodium borohydride chlorination condensation.
  • 相关文献

参考文献4

二级参考文献19

  • 1Buzdar A.;Jonat W.;Howwell A.;et al.,Anastrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carcinoma :results of a survival update based on a combined analysis of data from two mature phaseⅢtrials,Cancer ,1998 ,83 :1142-1152
  • 2Kaufmann M.;Bajetta E.;Dirix L.Y.;et al.,Exemestane is superior to megestrol acetate after tamoxifen failure in post menopausal women with advanced breast cancer ; results of a phase Ⅲrandomised double-blind study,J.Clin.Oncol ,2000 ,18 :1399-1411
  • 3Dombemowsky P.;Smith IE.;Falkson G.;et al.,Letrozole ,a new oral aromatase inhibitor for advanced breast cancer :double-blind randomised trial showing a dose-effect and improved efficacy and tolerability compared with megestrol acetate,J.Clin.Oncol ,1998 ,16 :453-461
  • 4Gershanovich M.;Chaudri HA.;Campos D.;et al.,Letrozole ,a new oral aromtase inhibitor :randomised trial comparing 2.5mg daily ,0.5 mg daily and aminoglutethimide in post menopausal women with advanced breast cancer,Ann On ology ,1998 ,9 :639-645
  • 5Nabholtz JM.;Buzdar A.;Pollak M.;et al.,Anastrozole is superior to tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women :results of a North American multicentre randomised trial ,J.Clin.Oncol ,2000 ,18 :3758-3767
  • 6Bonneterre J.;Thurlimann B.;Robertson J FR.;et al.,Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women :results of the tamoxifen or arimidex randomised group efficacy and tolerability study,J.Clin.Oncol ,2001 ,18:3748-3757
  • 7Mouridsen H.;Gershanovich M.;Sun Y.;et al.,Superior efficacy of Letrozole (Femara) versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer :results of a phase Ⅲstudy of the International Letrozole Breast Cancer Group,J.Clin.Oncol ,2001 ,19 :2596-2606
  • 8Miller WR.;Anderson TJ.;Hawkins RA.;et al.,Neoadjuvant endocrine treatment ,the Edinburgh experience[A] .Howell A ,Dowsett M.European School of Oncology Update Vol4-Primary Medical Therapy for Breast Cance,Amsterdam:Elsevier Science B.V.,1991,89-99
  • 9Marty M,Gershanovich M,Campos D,et al.Letrozole, a new potent, selective aromatase inhibitor superrior to aminoglutethimide in postmenopausal women with advanced breast cancer previously treated with antiestrogens〔J〕[].Proceedings of the American Society of Clinical Oncology.1997
  • 10Iveson TJ,Smith IE,Ahern J,et al.Phase Ⅰ study of the oral nonste-rioidal aromatase inhitor CGS 20267 in postmenopausal patients with advanced breast cancer〔J〕[].Cancer.1993

共引文献27

同被引文献3

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部